SMAD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.83442150358815E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.71169999788157E-08 |
Normal-vs-Stage2 |
3.55770000000089E-05 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.63358215843346E-12 |
Stage1-vs-Stage2 |
3.985200E-01 |
Stage1-vs-Stage3 |
1.03119999994572E-06 |
Stage1-vs-Stage4 |
4.11030000000423E-05 |
Stage2-vs-Stage3 |
4.221700E-02 |
Stage2-vs-Stage4 |
2.557600E-02 |
Stage3-vs-Stage4 |
7.361400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.03170813506404E-13 |
Normal-vs-AfricanAmerican |
1.48880000550022E-08 |
Normal-vs-Asian |
2.407400E-01 |
Caucasian-vs-AfricanAmerican |
6.970600E-01 |
Caucasian-vs-Asian |
1.720790E-01 |
AfricanAmerican-vs-Asian |
1.505360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.18474152499948E-14 |
Normal-vs-Female |
7.47700013015162E-10 |
Male-vs-Female |
1.311640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.00999999999674E-05 |
Normal-vs-Age(41-60Yrs) |
6.09730044232037E-10 |
Normal-vs-Age(61-80Yrs) |
1.64002145197628E-12 |
Normal-vs-Age(81-100Yrs) |
4.23890000000871E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.138600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.400200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.877400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.470300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.233800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.374800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.651200E-01 |
Normal-vs-Grade 2 |
9.53619999966016E-07 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.686590E-01 |
Grade 1-vs-Grade 3 |
3.392400E-04 |
Grade 1-vs-Grade 4 |
7.11919999951682E-07 |
Grade 2-vs-Grade 3 |
1.52949999998597E-06 |
Grade 2-vs-Grade 4 |
4.63380445125949E-11 |
Grade 3-vs-Grade 4 |
1.436480E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.64360000000286E-05 |
Normal-vs-ccB subtype |
1.62980740014973E-12 |
ccA subtype-vs-ccB subtype |
3.71799999676625E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.86104514816088E-12 |
Normal-vs-N1 |
1.71039999996569E-06 |
N0-vs-N1 |
2.564000E-01 |
|
|